ArticleOncology research2026

Prolonged Disease Stability with Durvalumab and Tremelimumab Rechallenge Following Prior Immune Checkpoint Inhibitors: A Case Report.

Waseem Abdelrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.